维普期刊资源整合服务平台（V6.5）

38篇 您的检索式：作者名="Mazzella G"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patients显示文摘AIM: To simultaneously evaluate the presence of defects in gallbladder and gastric emptying, as well as in intestinal transit in gallstone patients (GS) and the effect of chronic ursodeoxycholic acid (UDCA) administration on these parameters and on serum bile acids and clinical outcome in GS and controls (CTR). METHODS: After a standard liquid test meal, gallbla-dder and gastric emptying (by ultrasound), oroileal transit time (OITT) (by an immunoenzymatic technique) and serum bile acids (by HPLC) were evaluated before and after 3 mo of UDCA (12 mg/kg bw/d) or placebo administration in 10 symptomatic GS and 10 matched healthy CTR. RESULTS: OITT was longer in GS than in CTR (P < 0.0001); UDCA significantly reduced OITT in GS (P < 0.0001), but not in CTR. GS had longer gastric half-emptying time (t1/2) than CTR (P < 0.0044) at baseline; after UDCA, t1/2 significantly decreased (P < 0.006) in GS but not in CTR. Placebo administration had no effect on gastric emptying and intestinal transit in both GS and CTR. CONCLUSION: The gallstone patient has simultaneous multiple impairments of gallbladder and gastric emptying, as well as of intestinal transit. UDCA administration restores these defects in GS, without any effect in CTR. These results confirm the pathogenetic role of gastrointestinal motility in gallstone disease and suggest an additional mechanism of action for UDCA in reducing bile cholesterol supersaturation.	A Colecchia G Mazzella L Sandri F Azzaroli M Magliuolo P Simoni ML Bacchi-Reggiani E Roda D Festi	2006	World Journal of Gastroenterology2006，12，33：	4
2	Ursodeoxycholic acid administration in patients with cholestasis of pregnancy:effects on primary bile acids in babies and mothers显示文摘	Mazzella G Rizzo N Azzaroli F	2001	Heptology2001，33，：	1
3	Ursodeoxycholic acid administration in patients with cholestasis of pregnancy : effects on primary bile acids in babies and mothers显示文摘	Mazzella G Rizzo N Azzaroli F	2001	Hepatology2001，33，3：	1
4	Urs0de0xych0lic acid ad- ministration in patients with cholestasis of pregnancy : elects on primary bile acids in babies and mothers显示文摘	Mazzella G Rizzo N Azzaroli F	2001	Hepatology2001，33，3：	1
5	Rifaximin in the treatment of chronic hepatic encephalopathy ? resultes of a multicenter study of efficacy and safety显示文摘	Festi D Mazzella G Orsini M	1993	Current Therapeutic Research1993，54，5：	1
6	Long-term results with interferon therapy in chronic type B hepatitis:A prospective randomized trial显示文摘	Mazzella G Saracco G Festi D	1999	Am J Gastroenterol1999，94，8：	1
7	Safety of interferon beta treatment for chronic HCV hepatitis 显示文摘	Festi D Sandri L Mazzella G	2004	World J Gastroenterol2004，10，：	1
8	Acquired gallstone opacification during cholelitholytic treatment with chenodeoxyholic,ursodeoxycholic,and tauroursodeoxycholic acids显示文摘	Bazzoli F Festi D Mazzella G	1995	The American journal of gastroenterology1995，90，6：	1
9	Ursodeoxycholic acid administration in patients with cholestasis of pregnancy:effects on primary bile acid in babies and mothers显示文摘	Mazzella G Nicola R Francesco A	2001	Hepatology2001，33，3：	1
10	Sluggish small bowel motility is involved in determining increased biliary deoxycholic acid in cholesterol gallstone patients显示文摘	Mazzella G Mazzeo C	1999	Am J Gastroenterol1999，94，9：	1
11	Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial显示文摘	Mazzella G Saracco G Festi D	1999	Am J Gastroenterol1999，94，8：	1
12	Ursodeoxycholic acid ad ministration in pacients with cholestasis of pregnancy:effects on pri mary bile acids in babies and mothers 显示文摘	Mazzella G Rizzo N Azzaroli F	2001	Hepatology2001，33，：	1
13	Ursodexycholic acid administration in patients with cholestasis of pregnancy:effects on primary bile acids in babies and mothers显示文摘	MAZZELLA G NICOLA R FRANCESCO A	2001	Hepatology2001，33，：	1
14	Safety of interferon beta treatment for chronic HCV hepatitis显示文摘	Festi D Sandri L Mazzella G	2004	World J Gastroenterol2004，10，1：	1
15	Ursodcoxycholic acid administration in patient with cholestasis of pregnancy:effects on primary bile acids in babies and mothers显示文摘	Mazzella G Rizzo N Azzaroli F	2001	Hepatology2001，33，3：	1
16	Ursodeoxycholic acid administra tion in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers 显示文摘	Mazzella G Rizzo N Azzaroli F	2001	Hepatology2001，33，3：	1
17	Ursodexycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers显示文摘	Mazzella G Nicola R Francesco A	2001	Hepatology2001，33，：	1
18	Ursodexy cholic acid administration in patients with cholestasis of pregnancy : effects on primary bile acid in babies and mothers 显示文摘	Mazzella G Nicola R Francesco A	2001	Hepatology2001，33，3：	1
19	Ursodexycholic acid administration in patients with cholestasis of pregnancy:effects on primary bile acid in babies and mothers显示文摘	Nicola R Francesco A	2001	Hepatology2001，33，3：	1
20	查看详情显示文摘	Tuteja A Choi W Ma M Mabry J M Mazzella S A Rutledge G C McKinley G H Cohen R E		0，，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示